Home
Innate Pharma

Innate Pharma Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domaininnate-pharma.com

Year Founded1999

Employees201 - 500

Annual Revenue$25M - $50M

Innate Pharma

Innate Pharma (including company regionals)

innate-pharma.com

See more website traffic and engagement information

Innate Pharma Revenue up to November 2025 is 25M - 50M

revenue generated by Innate Pharma top domains

Innate Pharma top domains revenue over 3 years

Revenue for Innate Pharma top domains

innate-pharma.com25M - 50M

See more with Sales Intelligence

Total visits to Innate Pharma's top domains

Understand Innate Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

innate-pharma.com10.7K

See more with Sales Intelligence

Avg. visit duration in Innate Pharma's top domains

Analyze Innate Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

innate-pharma.com00:00:34

See more with Sales Intelligence

Avg. pageviews on Innate Pharma's top domains

See how Innate Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

innate-pharma.com1.78

See more with Sales Intelligence

Innate Pharma top competitors by domain

Top similar sites in November 2025, ranked by their affinity

ipsen.comCompany NameIpsenEmployees5001 - 10000HQFrance, Boulogne-BillancourtAnnual revenue> $1BTotal visits86.6KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Innate Pharma

These are the website technologies, by industry, used by Innate Pharma top domains

Advertising (5)

Google Adsense

Payment & Currencies (5)

PayPal

Social (4)

Twitter

Audio Video Media (3)

YouTube

More Technologies

9

See all

News & Signals from Innate Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsInnate Pharma, Inc. launched 2026 financial calendar on Dec 11th '25.Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today released its 2026 financial calendar:

NewsInnate Pharma, Inc. attended event Jefferies Global Healthcare Conference 2025 on Nov 17th '25.Innate Pharma SA (euronext paris: IPH; nasdaq: IPHA) ("Innate" or the "company") today announces its participation in the jefferies Global Healthcare Conference 2025.

NewsInnate Pharma, Inc. attended event European Midcap Event on Sep 15th '25.Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that Frédéric Lombard, Chief financial Officer of the Company, will participate in the 25th edition of the European Midcap Event being held from September 30 to October 1, 2025 in Paris, France.